tradingview
Indivior Pharmaceuticals, Inc. 2026: Revenue $343M, EPS $0.98— 10-Q Summary
Indivior Pharmaceuticals, Inc. reported results for the quarter ended 2026 with revenue of $343M and diluted EPS of $0.98, reflecting year-over-year improvement driven by SUBLOCADE volume and mix.Financial Highlights¹ Reported as “Net revenue”. ² Reported as “Net income”. ³ Reported as “Diluted ear…